MERLINE COVINGTON: Open Payments
NPI 1104460930 · HOLLISTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 13 payments from 7 companies in 2025. Trend: 2023 $145 · 2024 $0 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Tris Pharma Inc | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: INGREZZA, COBENFY, UZEDY, VRAYLAR, HETLIOZ, Dyanavel XR, Auvelity.
Industry payments across CA — which companies pay providers there.
